Cargando…
Clinical and economic impact of the introduction of a nucleic acid amplification assay for Clostridium difficile
BACKGROUND: The clinical outcomes and cost implications of a diagnostic shift from an EIA- to PCR-based assay for Clostridium difficile infection (CDI) have not been completely described in the literature. METHODS: The impact of the PCR-based assay on the incidence and duration of CDI therapy was co...
Autores principales: | Guinta, Margaret M., Bunnell, Kristen, Harrington, Amanda, Bleasdale, Susan, Danziger, Larry, Wenzler, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713042/ https://www.ncbi.nlm.nih.gov/pubmed/29202797 http://dx.doi.org/10.1186/s12941-017-0252-7 |
Ejemplares similares
-
Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin
por: Bunnell, Kristen L., et al.
Publicado: (2017) -
The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
por: Wenzler, Eric, et al.
Publicado: (2015) -
Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections
por: Santibañez, Melissa, et al.
Publicado: (2019) -
Impact of the introduction of a nucleic acid amplification test for Clostridium difficile diagnosis on stool rejection policies
por: Goret, J., et al.
Publicado: (2018) -
Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)